AT

Ankapura Thimme Gowda

Active Director Designated Partner DIN 10396958
DIN 10396958 First appointment Nov 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankapura Thimme Gowda

Data last updated:

Ankapura Thimme Gowda is a Designated Partner at Inovision Clinical Research Services Llp (since 2023). The company operates in Healthcare.

DIN 10396958
Primary Designation Designated Partner
Industry Healthcare
First Appointment 20 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Nov 20232023Active

Board colleagues of Ankapura Thimme Gowda

Directorship timeline

Open interactive timeline →
Inovision Clinical Research Services Llp
Premium access

Shareholding and investment profile for Ankapura Thimme Gowda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankapura Thimme Gowda

Ankapura Thimme Gowda currently holds 1 directorship: Inovision Clinical Research Services Llp (Designated Partner, since 20 Nov 2023).

Ankapura Thimme Gowda was first appointed on 20 Nov 2023 as Designated Partner at Inovision Clinical Research Services Llp.

The current boards of Ankapura Thimme Gowda's companies include Nutan Pattanayak (Inovision Clinical Research Services Llp), Bare Palya Shivaramaiah Sudarshan (Inovision Clinical Research Services Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available